Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease
- 1 September 1987
- journal article
- research article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 8 (3) , 216-242
- https://doi.org/10.1016/0197-2456(87)90046-8
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Atherosclerosis, calcium, and calcium antagonists.Circulation, 1985
- Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.Circulation, 1985
- The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Effect of Ca2+ blocking agents on the metabolism of low density lipoproteins in human skin fibroblastsBiochemical and Biophysical Research Communications, 1982
- Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: results at repeat angiography.Circulation, 1982
- Progression of coronary atherosclerosis.Circulation, 1981
- Controversy in Counting and Attributing Events in Clinical TrialsNew England Journal of Medicine, 1979
- Observer agreement in evaluating coronary angiograms.Circulation, 1975
- Progression of Coronary Artery DiseaseCirculation, 1973